.png)
Anagram Therapeutics Page
Anagram Therapeutics
Anagram Therapeutics
Join us for the 2026 Uncork the Cure:
Omni Boston Hotel at the Seaport
Omni Boston Hotel at the Seaport
An evening filled with exceptional wine, fabulous food, and unique auction items!
Date: November 7th, 2026Location: Omni Boston Hotel Seaport 450 Summer St. Boston, MA
6:00pm VIP
7:00pm Grand tasting
I invite you to join me at this incredible event or donate in honor of the work Bob Gallotto, his teams, and his partners have excelled at over the years.
Anagram is raising money for the CF Foundation. Outright donations through this fundraising page will be restricted to the DIGEST program to help support better gastrointestinal care in people with cystic fibrosis. Recognizing the growing demand for physicians who are trained to address the unique gastroenterological needs of people with cystic fibrosis and the need for a greater focus on gastrointestinal issues, the Cystic Fibrosis Foundation along with Dr. Steven Freedman, Dr. Sarah-Jane Schwarzenberg and Dr. Drucy Borowitz created the DIGEST (Developing Innovative Gastroenterology Specialty Training) program. The DIGEST program has successfully trained both pediatric and adult gastroenterologists on the unique gastrointestinal manifestations associated with cystic fibrosis. The DIGEST program plays a critical role into the future as the Foundation increases its focus on addressing gastrointestinal symptoms and disease for people with CF. All funds and sponsorships that we raise will go directly to the DIGEST program. Donate or become a DIGEST sponsor.
FOR MORE INFORMATION OR TO MAKE A GENERAL DONATION CLICK DONATE →
Breath of Life Honoree
Robert Gallotto is the Founder, President and Chief Executive Officer of Anagram Therapeutics. With 35 years of experience in the pharmaceutical industry, he has dedicated his career to building companies focusing on cystic fibrosis (CF) and other rare diseases. Before joining Anagram, Mr. Gallotto co-founded and served as President of Alcresta Therapeutics, where he led the company from inception to the successful launch of RELiZORB. This innovative medical device originally developed for people with CF earned the 2016 Medical Device Design Excellence Gold Medal Award. He has worked closely with the Cystic Fibrosis Foundation for 25+ and is the inventor of multiple patents. In addition, he co-founded Allena Pharmaceuticals as well as Alnara Pharmaceuticals and held leadership roles at Altus Pharmaceuticals, Biogen, Ares-Serono, Sage BioPharma, and The Upjohn Company. Mr. Gallotto received the distinguished Frances Pew Hayes Hope in Action Award in 2010 for his efforts in furthering the mission of the CF Foundation. Mr. Gallotto has also been part of 5 corporate team of year awards from the Cystic Fibrosis Foundation.
Comments